Takeda Announces FDA Acceptance of BLA for Subcutaneous Administration of ENTYVIO (vedolizumab) for Maintenance Therapy in Moderately to Severely Active Crohn’s Disease Read more
Dewpoint Therapeutics Partners with Chemify to Apply Groundbreaking Chemistry AI to Radically Accelerate the Discovery of Molecules Targeting Cancer and Neurodegeneration Read more
Sandoz announces exclusive deal to commercialize biosimilar ustekinumab, further reinforcing growing pipeline and immunology patient offering Read more
Biocytogen Enters into Antibody Evaluation, Option and License Agreement with Myricx for ADC Development Read more
Broad Institute of MIT and Harvard announces a new research alliance with Novo Nordisk to identify therapeutic targets for type 2 diabetes and cardiometabolic diseases Read more
TC BioPharm Announces Grant Funding in Collaboration with Queen Mary University of London (QMUL) Read more
Veracyte and Gustave Roussy Announce Collaboration to Help Biopharmaceutical Companies Accelerate Development of Novel Cancer Therapies Read more